Joanne Wuensch
Stock Analyst at Citigroup
(4.43)
# 300
Out of 4,876 analysts
384
Total ratings
64.09%
Success rate
12.3%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Neutral | $20 → $24 | $19.11 | +25.59% | 15 | May 22, 2025 | |
| SYK Stryker | Maintains: Buy | $443 → $455 | $390.40 | +16.55% | 14 | May 22, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.2 → $3.6 | $4.25 | -15.29% | 11 | May 22, 2025 | |
| LUNG Pulmonx | Maintains: Neutral | $6.5 → $4.15 | $2.59 | +60.23% | 11 | May 22, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $130 → $167 | $152.69 | +9.37% | 18 | May 22, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $590 → $650 | $534.19 | +21.68% | 17 | May 22, 2025 | |
| PODD Insulet | Maintains: Buy | $320 → $380 | $309.83 | +22.65% | 15 | May 22, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $84 → $95 | $77.15 | +23.14% | 20 | May 22, 2025 | |
| DXCM DexCom | Maintains: Buy | $82 → $102 | $85.04 | +19.94% | 14 | May 22, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $119 → $125 | $104.58 | +19.53% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $121.87 | +14.88% | 5 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $13 | $12.07 | +7.71% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $105 → $86 | $74.86 | +14.88% | 4 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $110 | $69.69 | +57.84% | 20 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $160 | $133.67 | +19.70% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $92 → $107 | $86.18 | +24.16% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $200 → $245 | $253.58 | -3.38% | 24 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $175 | $152.01 | +15.12% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $37 → $35 | $30.50 | +14.75% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $101.06 | +60.30% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $12.21 | +80.18% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $45 → $50 | $40.84 | +22.43% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $85 | $74.77 | +13.68% | 7 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $91.74 | +30.80% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $169.97 | +47.08% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $87.11 | -20.79% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $256.21 | -50.43% | 6 | Dec 10, 2018 |
Tandem Diabetes Care
May 22, 2025
Maintains: Neutral
Price Target: $20 → $24
Current: $19.11
Upside: +25.59%
Stryker
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $390.40
Upside: +16.55%
Sight Sciences
May 22, 2025
Maintains: Neutral
Price Target: $3.2 → $3.6
Current: $4.25
Upside: -15.29%
Pulmonx
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $2.59
Upside: +60.23%
iRhythm Technologies
May 22, 2025
Maintains: Buy
Price Target: $130 → $167
Current: $152.69
Upside: +9.37%
Intuitive Surgical
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $534.19
Upside: +21.68%
Insulet
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $309.83
Upside: +22.65%
Edwards Lifesciences
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $77.15
Upside: +23.14%
DexCom
May 22, 2025
Maintains: Buy
Price Target: $82 → $102
Current: $85.04
Upside: +19.94%
Boston Scientific
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $104.58
Upside: +19.53%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $121.87
Upside: +14.88%
May 1, 2025
Maintains: Neutral
Price Target: $14 → $13
Current: $12.07
Upside: +7.71%
Apr 30, 2025
Maintains: Buy
Price Target: $105 → $86
Current: $74.86
Upside: +14.88%
Mar 7, 2025
Maintains: Buy
Price Target: $115 → $110
Current: $69.69
Upside: +57.84%
Mar 4, 2025
Maintains: Buy
Price Target: $135 → $160
Current: $133.67
Upside: +19.70%
Mar 4, 2025
Upgrades: Buy
Price Target: $92 → $107
Current: $86.18
Upside: +24.16%
Dec 11, 2024
Maintains: Neutral
Price Target: $200 → $245
Current: $253.58
Upside: -3.38%
Dec 11, 2024
Maintains: Buy
Price Target: $185 → $175
Current: $152.01
Upside: +15.12%
Dec 11, 2024
Maintains: Neutral
Price Target: $37 → $35
Current: $30.50
Upside: +14.75%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $101.06
Upside: +60.30%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $12.21
Upside: +80.18%
Oct 1, 2024
Maintains: Neutral
Price Target: $45 → $50
Current: $40.84
Upside: +22.43%
Aug 22, 2024
Maintains: Neutral
Price Target: $94 → $85
Current: $74.77
Upside: +13.68%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $91.74
Upside: +30.80%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $169.97
Upside: +47.08%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $87.11
Upside: -20.79%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $256.21
Upside: -50.43%